HEADER TRANSFERASE 10-APR-15 4ZZM TITLE HUMAN ERK2 IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 11-360; COMPND 5 SYNONYM: MAP KINASE 1, MAPK 1, ERT1, EXTRACELLULAR SIGNAL-REGULATED COMPND 6 KINASE 2, ERK-2, MAP KINASE ISOFORM P42, P42-MAPK, COMPND 7 MITOGEN-ACTIVATED PROTEIN KINASE 2, MAP KINASE 2, MAPK 2; COMPND 8 EC: 2.7.11.24; COMPND 9 ENGINEERED: YES; COMPND 10 OTHER_DETAILS: MODIFIED CYS 161 A SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.A.WARD,N.COLCLOUGH,M.CHALLINOR,J.E.DEBRECZENI,K.ECKERSLEY, AUTHOR 2 G.FAIRLEY,L.FERON,V.FLEMINGTON,M.A.GRAHAM,R.GREENWOOD,P.HOPCROFT, AUTHOR 3 T.D.HOWARD,M.JAMES,C.D.JONES,C.R.JONES,J.RENSHAW,K.ROBERTS,L.SNOW, AUTHOR 4 M.TONGE,K.YEUNG REVDAT 2 26-AUG-15 4ZZM 1 JRNL REVDAT 1 27-MAY-15 4ZZM 0 JRNL AUTH R.A.WARD,N.COLCLOUGH,M.CHALLINOR,J.DEBRECZENI,K.ECKERSLEY, JRNL AUTH 2 G.FAIRLEY,L.FERON,V.FLEMINGTON,M.A.GRAHAM,R.GREENWOOD, JRNL AUTH 3 P.HOPCROFT,T.D.HOWARD,M.JAMES,C.D.JONES,C.R.JONES,J.RENSHAW, JRNL AUTH 4 K.ROBERTS,L.SNOW,M.TONGE,K.YEUNG JRNL TITL STRUCTURE-GUIDED DESIGN OF HIGHLY SELECTIVE AND POTENT JRNL TITL 2 COVALENT INHIBITORS OF ERK1/2. JRNL REF J.MED.CHEM. V. 58 4790 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 25977981 JRNL DOI 10.1021/ACS.JMEDCHEM.5B00466 REMARK 2 REMARK 2 RESOLUTION. 1.89 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,WOMACK; REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.89 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.18 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.0 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.32 REMARK 3 NUMBER OF REFLECTIONS : 30183 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.2104 REMARK 3 R VALUE (WORKING SET) : 0.2073 REMARK 3 FREE R VALUE : 0.2544 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.30 REMARK 3 FREE R VALUE TEST SET COUNT : 1903 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.89 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.96 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.72 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2899 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.3383 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2693 REMARK 3 BIN R VALUE (WORKING SET) : 0.3331 REMARK 3 BIN FREE R VALUE : 0.4137 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.11 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 206 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2707 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 121 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.17 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.19 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.7015 REMARK 3 B22 (A**2) : -4.3448 REMARK 3 B33 (A**2) : 1.6433 REMARK 3 B12 (A**2) : 0.0000 REMARK 3 B13 (A**2) : 2.7800 REMARK 3 B23 (A**2) : 0.0000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.279 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.152 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.147 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.154 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.149 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.9451 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.9095 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2812 ; 2.00 ; HARMONIC REMARK 3 BOND ANGLES : 3832 ; 2.00 ; HARMONIC REMARK 3 TORSION ANGLES : 950 ; 2.00 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 65 ; 2.00 ; HARMONIC REMARK 3 GENERAL PLANES : 405 ; 5.00 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2812 ; 20.00 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 373 ; 5.00 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3313 ; 4.00 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.99 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.84 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.76 REMARK 3 REMARK 3 TLS DETAILS. REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -4.3088 8.6977 47.3800 REMARK 3 T TENSOR REMARK 3 T11: 0.0314 T22: -0.2071 REMARK 3 T33: -0.1029 T12: 0.0029 REMARK 3 T13: 0.0788 T23: 0.0149 REMARK 3 L TENSOR REMARK 3 L11: 0.7440 L22: 0.4498 REMARK 3 L33: 0.9866 L12: 0.2453 REMARK 3 L13: 0.1565 L23: 0.1753 REMARK 3 S TENSOR REMARK 3 S11: -0.0302 S12: 0.0878 S13: 0.0565 REMARK 3 S21: -0.0630 S22: 0.0380 S23: 0.0116 REMARK 3 S31: -0.0869 S32: 0.0007 S33: -0.0078 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IDEAL-DIST CONTACT TERM CONTACT SETUP. REMARK 3 ALL ATOMS HAVE CCP4 ATOM TYPE FROM LIBRARY REMARK 4 REMARK 4 4ZZM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-APR-15. REMARK 100 THE PDBE ID CODE IS EBI-63584. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL (PILATUS) REMARK 200 DETECTOR MANUFACTURER : DECTRIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30202 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.89 REMARK 200 RESOLUTION RANGE LOW (A) : 46.18 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 200 DATA REDUNDANCY : 3.2 REMARK 200 R MERGE (I) : 0.09 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.10 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.89 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.94 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.2 REMARK 200 R MERGE FOR SHELL (I) : 0.57 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.90 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.15500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 356 REMARK 465 GLY A 357 REMARK 465 TYR A 358 REMARK 465 ARG A 359 REMARK 465 SER A 360 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 12 CG CD OE1 OE2 REMARK 470 LYS A 48 CG CD CE NZ REMARK 470 GLU A 60 CG CD OE1 OE2 REMARK 470 ARG A 79 CD NE CZ NH1 NH2 REMARK 470 LYS A 99 CG CD CE NZ REMARK 470 GLU A 109 CG CD OE1 OE2 REMARK 470 LYS A 114 CD CE NZ REMARK 470 LYS A 117 CG CD CE NZ REMARK 470 GLU A 186 CG CD OE1 OE2 REMARK 470 TYR A 187 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 203 CD CE NZ REMARK 470 LYS A 231 CG CD CE NZ REMARK 470 GLU A 250 CG CD OE1 OE2 REMARK 470 ARG A 277 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 300 CD CE NZ REMARK 470 GLU A 326 CD OE1 OE2 REMARK 470 LYS A 330 CG CD CE NZ REMARK 470 PHE A 331 CG CD1 CD2 CE1 CE2 CZ REMARK 470 MET A 333 CG SD CE REMARK 470 GLU A 334 CG CD OE1 OE2 REMARK 470 ASP A 336 CG OD1 OD2 REMARK 470 ASP A 337 CG OD1 OD2 REMARK 470 LYS A 340 CG CD CE NZ REMARK 470 LYS A 342 CG CD CE NZ REMARK 470 GLU A 349 CG CD OE1 OE2 REMARK 470 GLU A 350 CG CD OE1 OE2 REMARK 470 ARG A 353 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 36 5.14 53.27 REMARK 500 ASP A 149 40.23 -143.85 REMARK 500 ASP A 167 85.43 56.15 REMARK 500 ALA A 189 -177.02 65.00 REMARK 500 ASN A 201 15.24 -158.57 REMARK 500 LEU A 294 50.25 -94.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 COMPOUND COVALENTLY BOUND TO PROTEIN 166 CYS A REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A1356 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CQ6 A1357 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4ZZN RELATED DB: PDB REMARK 900 HUMAN ERK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 4ZZO RELATED DB: PDB REMARK 900 HUMAN ERK2 IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR DBREF 4ZZM A 11 360 UNP P28482 MK01_HUMAN 11 360 SEQADV 4ZZM LEU A 46 UNP P28482 VAL 46 CONFLICT SEQRES 1 A 350 PRO GLU MET VAL ARG GLY GLN VAL PHE ASP VAL GLY PRO SEQRES 2 A 350 ARG TYR THR ASN LEU SER TYR ILE GLY GLU GLY ALA TYR SEQRES 3 A 350 GLY MET VAL CYS SER ALA TYR ASP ASN LEU ASN LYS VAL SEQRES 4 A 350 ARG VAL ALA ILE LYS LYS ILE SER PRO PHE GLU HIS GLN SEQRES 5 A 350 THR TYR CYS GLN ARG THR LEU ARG GLU ILE LYS ILE LEU SEQRES 6 A 350 LEU ARG PHE ARG HIS GLU ASN ILE ILE GLY ILE ASN ASP SEQRES 7 A 350 ILE ILE ARG ALA PRO THR ILE GLU GLN MET LYS ASP VAL SEQRES 8 A 350 TYR ILE VAL GLN ASP LEU MET GLU THR ASP LEU TYR LYS SEQRES 9 A 350 LEU LEU LYS THR GLN HIS LEU SER ASN ASP HIS ILE CYS SEQRES 10 A 350 TYR PHE LEU TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE SEQRES 11 A 350 HIS SER ALA ASN VAL LEU HIS ARG ASP LEU LYS PRO SER SEQRES 12 A 350 ASN LEU LEU LEU ASN THR THR CME ASP LEU LYS ILE CYS SEQRES 13 A 350 ASP PHE GLY LEU ALA ARG VAL ALA ASP PRO ASP HIS ASP SEQRES 14 A 350 HIS THR GLY PHE LEU THR GLU TYR VAL ALA THR ARG TRP SEQRES 15 A 350 TYR ARG ALA PRO GLU ILE MET LEU ASN SER LYS GLY TYR SEQRES 16 A 350 THR LYS SER ILE ASP ILE TRP SER VAL GLY CYS ILE LEU SEQRES 17 A 350 ALA GLU MET LEU SER ASN ARG PRO ILE PHE PRO GLY LYS SEQRES 18 A 350 HIS TYR LEU ASP GLN LEU ASN HIS ILE LEU GLY ILE LEU SEQRES 19 A 350 GLY SER PRO SER GLN GLU ASP LEU ASN CYS ILE ILE ASN SEQRES 20 A 350 LEU LYS ALA ARG ASN TYR LEU LEU SER LEU PRO HIS LYS SEQRES 21 A 350 ASN LYS VAL PRO TRP ASN ARG LEU PHE PRO ASN ALA ASP SEQRES 22 A 350 SER LYS ALA LEU ASP LEU LEU ASP LYS MET LEU THR PHE SEQRES 23 A 350 ASN PRO HIS LYS ARG ILE GLU VAL GLU GLN ALA LEU ALA SEQRES 24 A 350 HIS PRO TYR LEU GLU GLN TYR TYR ASP PRO SER ASP GLU SEQRES 25 A 350 PRO ILE ALA GLU ALA PRO PHE LYS PHE ASP MET GLU LEU SEQRES 26 A 350 ASP ASP LEU PRO LYS GLU LYS LEU LYS GLU LEU ILE PHE SEQRES 27 A 350 GLU GLU THR ALA ARG PHE GLN PRO GLY TYR ARG SER MODRES 4ZZM CME A 161 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 161 10 HET SO4 A1356 5 HET CQ6 A1357 22 HETNAM CQ6 7-ETHYLSULFONYL-N-(OXAN-4-YL)-6,8-DIHYDRO-5H- HETNAM 2 CQ6 PYRIDO[3,4-D]PYRIMIDIN-2-AMINE HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM SO4 SULFATE ION FORMUL 2 CQ6 C14 H22 N4 O3 S FORMUL 3 CME C5 H11 N O3 S2 FORMUL 4 SO4 O4 S 2- FORMUL 5 HOH *121(H2 O) HELIX 1 1 HIS A 61 PHE A 78 1 18 HELIX 2 2 LEU A 112 GLN A 119 1 8 HELIX 3 3 SER A 122 ALA A 143 1 22 HELIX 4 4 LYS A 151 SER A 153 5 3 HELIX 5 5 ASP A 175 ASP A 179 5 5 HELIX 6 6 THR A 190 ARG A 194 5 5 HELIX 7 7 ALA A 195 ASN A 201 1 7 HELIX 8 8 LYS A 207 ASN A 224 1 18 HELIX 9 9 LEU A 234 GLY A 245 1 12 HELIX 10 10 SER A 248 CYS A 254 1 7 HELIX 11 11 ASN A 257 LEU A 267 1 11 HELIX 12 12 PRO A 274 PHE A 279 1 6 HELIX 13 13 ASP A 283 LEU A 294 1 12 HELIX 14 14 GLU A 303 ALA A 309 1 7 HELIX 15 15 HIS A 310 GLU A 314 5 5 HELIX 16 16 ASP A 318 GLU A 322 5 5 HELIX 17 17 PRO A 339 ALA A 352 1 14 HELIX 18 18 ARG A 353 GLN A 355 5 3 SHEET 1 AA 5 TYR A 25 GLY A 34 0 SHEET 2 AA 5 GLY A 37 ASP A 44 -1 O GLY A 37 N GLY A 34 SHEET 3 AA 5 VAL A 49 ILE A 56 -1 O VAL A 49 N ASP A 44 SHEET 4 AA 5 VAL A 101 ASP A 106 -1 O VAL A 101 N ILE A 56 SHEET 5 AA 5 ASP A 88 ILE A 90 -1 O ASP A 88 N VAL A 104 SHEET 1 AB 3 THR A 110 ASP A 111 0 SHEET 2 AB 3 LEU A 155 LEU A 157 -1 O LEU A 157 N THR A 110 SHEET 3 AB 3 LEU A 163 ILE A 165 -1 O LYS A 164 N LEU A 156 SHEET 1 AC 2 VAL A 145 LEU A 146 0 SHEET 2 AC 2 ARG A 172 VAL A 173 -1 O ARG A 172 N LEU A 146 LINK C THR A 160 N CME A 161 1555 1555 1.34 LINK C CME A 161 N ASP A 162 1555 1555 1.35 LINK SG CYS A 166 C CQ6 A1357 1555 1555 1.82 CISPEP 1 GLY A 22 PRO A 23 0 0.18 SITE 1 AC1 5 ARG A 191 ARG A 194 TYR A 233 HOH A2062 SITE 2 AC1 5 HOH A2079 SITE 1 AC2 11 ALA A 52 LYS A 54 GLN A 105 ASP A 106 SITE 2 AC2 11 MET A 108 GLU A 109 THR A 110 ASP A 111 SITE 3 AC2 11 CYS A 166 ASP A 167 HOH A2055 CRYST1 48.880 70.310 60.410 90.00 109.12 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020458 0.000000 0.007092 0.00000 SCALE2 0.000000 0.014223 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017520 0.00000